| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Jun 3, 2014System monitors respiration rate, oxygen saturation and pulse rate from a single, finger sensor
DUBLIN, Ireland--(BUSINESS WIRE)--Jun. 3, 2014-- Covidien plc, a leading global provider of health care products and recognized innovator in patient monitoring and respiratory care devices, today...
-
Jun 2, 2014Medtronic Will Donate $10 to Project HOPE for Every Story Shared Online
MINNEAPOLIS - June 2, 2014- Medtronic, Inc. (NYSE: MDT) today opened 2014 award applications for the Bakken Invitation, a global program designed to celebrate and connect people who, with the help...
-
May 24, 2014
HeartWare International, Inc. (Nasdaq: HTWR) today announced issuance of a clinician and patient reminder concerning the Urgent Medical Device Correction distributed to all of its clinical sites...
-
May 21, 2014Rigorous Two-Year Analyses Presented at EuroPCR 2014 Affirm Safety, Efficacy and Sustained Valve Performance of Self-Expanding Valve
PARIS and MINNEAPOLIS - May 21, 2014 - Medtronic, Inc. (NYSE: MDT) today revealed new data showing that patients treated with the CoreValve® System experienced positive clinical outcomes in the...
-
May 21, 2014ILLUMENATE First-in-Human Clinical Trial Supports the Stellarex™ Balloon with EnduraCoat™ Technology in Treating Peripheral Arterial Disease
PARIS--(BUSINESS WIRE)--May 22, 2014-- Covidien’s Stellarex™ drug-coated angioplasty balloon (Stellarex DCB) continues to be shown as safe and effective for treatment of peripheral arterial...
-
May 20, 2014Q4 Revenue of $4.6 Billion Grew 3% at Constant Currency; 2% as Reported
MINNEAPOLIS - May 20, 2014 - Medtronic, Inc. (NYSE: MDT) today announced financial results for its fourth quarter and fiscal year 2014, which ended April 25, 2014. The company reported worldwide...
-
May 20, 2014Noncompliant Balloon Provides Superior Deliverability and Controlled Growth for Challenging Coronary Angioplasty Procedures
MINNEAPOLIS -- May 20, 2014 -- Continuing its commitment to bringing advanced and clinically relevant interventional technologies to market, Medtronic, Inc. (NYSE: MDT) today announced CE (Conformité
-
May 13, 2014
MINNEAPOLIS - May 13, 2014 - Medtronic, Inc. (NYSE: MDT) announced today it will report financial results for the fourth quarter and fiscal year 2014 on Tuesday, May 20, 2014. A news release will...
-
May 10, 2014Late-breaking Clinical Trial Data Confirm Industry Leadership with 1 Percent Inappropriate Shocks Using Medtronic SmartShock Technology
MINNEAPOLIS and SAN FRANCISCO - May 10, 2014 - Medtronic, Inc. (NYSE: MDT) today announced the results from the first prospective randomized clinical trial to show that Medtronic implantable...
-
May 10, 2014MINERVA Trial Presented at Heart Rhythm Meeting Shows Medtronic Advanced Pacing Features Reduce the Progression of Persistent AF by 58 Percent While Reducing AF-Related Hospital Visits That Lead to Increased Healthcare Costs
MINNEAPOLIS and SAN FRANCISCO - May 10, 2014 - New data presented as a late-breaking clinical trial at the Heart Rhythm Society's 2014 Annual Scientific Sessions show that an advanced pacing...